Yigal Nochomovitz Analyst PerformanceDirector, Biotech Equity Research at CitigroupYigal Nochomovitz is a stock analyst at Citigroup focused in the medical sector, covering 44 publicly traded companies. Over the past year, Yigal Nochomovitz has issued 28 stock ratings, including buy, hold, and sell recommendations. While full access to Yigal Nochomovitz's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yigal Nochomovitz's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings123 Last 10 YearsBuy Recommendations74.11% 83 Buy RatingsCompanies Covered44 Unique Companies Ratings Distribution112RatingsDistribution of strong buy, buy, hold, and sell ratings by Yigal Nochomovitz.RatingPercentageCount Strong Buy0.0%0 ratings Buy74.1%83 ratings Hold21.4%24 ratings Sell4.5%5 ratingsOut of 112 total stock ratings issued by Yigal Nochomovitz at Citigroup, the majority (74.1%) have been Buy recommendations, followed by 21.4% Hold and 4.5% Sell.Best & Worst CallsBest Call0000.0%LOXOJun 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%OPHTOct 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ95.5% of companies on NASDAQ42 companiesNYSE2.3% of companies on NYSE1 companyOTCMKTS2.3% of companies on OTCMKTS1 companyYigal Nochomovitz, an analyst at Citigroup, currently covers 44 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical42 companies95.5%Miscellaneous2 companies4.5%Yigal Nochomovitz of Citigroup specializes in stock coverage within the Medical sector, with additional focus on companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE25 companies56.8%PHARMACEUTICAL PREPARATIONS10 companies22.7%MED - DRUGS4 companies9.1%Miscellaneous2 companies4.5%MED PRODUCTS1 company2.3%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company2.3%MISCELLANEOUS HEALTH & ALLIED SERVICES1 company2.3% Yigal Nochomovitz's Ratings History at Citigroup Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAVBPArriVent BioPharma8/12/2025Reiterated Rating$17.42$33.00Buy$0.0000.00% ROIARCTArcturus Therapeutics8/12/2025Reiterated Rating$11.39$49.00Buy$0.0000.00% ROIOLMAOlema Pharmaceuticals8/12/2025Boost Price Target$4.57$21.00Buy$0.0000.00% ROIZLABZai Lab8/11/2025Reiterated Rating$34.96$69.00Buy$0.0000.00% ROIBMEABiomea Fusion8/11/2025Lower Price Target$1.55$7.00Buy$0.0000.00% ROIZYMEZymeworks8/11/2025Boost Price Target$11.94$22.00Buy$0.0000.00% ROILXRXLexicon Pharmaceuticals8/7/2025Boost Price Target$1.12$1.90Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals8/5/2025Boost Price Target$12.59$51.00Buy$0.0000.00% ROIKRYSKrystal Biotech8/5/2025Reiterated Rating$135.38$166.00Neutral$0.0000.00% ROILENZLENZ Therapeutics7/31/2025Reiterated Rating$30.58$49.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. APLSApellis Pharmaceuticals7/29/2025Boost Price Target$18.50$46.00Buy$0.0000.00% ROISRPTSarepta Therapeutics7/22/2025Initiated Coverage$13.32Sell$0.0000.00% ROIBMEABiomea Fusion7/16/2025Lower Price Target$1.87$9.00Buy$0.0000.00% ROIPROKProKidney7/9/2025Reiterated Rating$4.70$9.00Buy$0.0000.00% ROISLDBSolid Biosciences6/26/2025Initiated Coverage$4.74$14.00Buy$0.0000.00% ROIAPLSApellis Pharmaceuticals5/22/2025Lower Price Target$17.49$41.00Buy$0.0000.00% ROIKRYSKrystal Biotech5/16/2025Lower Price Target$130.60$155.00Neutral$0.0000.00% ROIARVNArvinas5/5/2025Lower Price Target$7.63$9.50Neutral$0.0000.00% ROIARDXArdelyx5/2/2025Lower Price Target$4.13$10.00Buy$0.0000.00% ROISMMTSummit Therapeutics3/26/2025Set Price Target$15.86$35.00$0.0000.00% ROILENZLENZ Therapeutics3/20/2025Boost Price Target$26.29$47.00Buy$0.0000.00% ROIARVNArvinas3/7/2025Lower Price Target$18.28$19.00Neutral$0.0000.00% ROIZYMEZymeworks3/7/2025Boost Price Target$12.00$19.00Buy$0.0000.00% ROIRIGLRigel Pharmaceuticals3/6/2025Boost Price Target$20.18$55.00Buy$0.0000.00% ROISNDXSyndax Pharmaceuticals3/4/2025Lower Price Target$14.48$42.00Buy$0.0000.00% ROICADLCandel Therapeutics2/20/2025Initiated Coverage$10.47$25.00Buy$0.0000.00% ROIKRYSKrystal Biotech2/20/2025Boost Price Target$181.64$215.00Neutral$0.0000.00% ROICRSPCRISPR Therapeutics2/18/2025Lower Price Target$52.29$82.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
